BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren Y, Landegger LD, Stankovic KM. Gene Therapy for Human Sensorineural Hearing Loss. Front Cell Neurosci 2019;13:323. [PMID: 31379508 DOI: 10.3389/fncel.2019.00323] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Reisinger E. Dual-AAV delivery of large gene sequences to the inner ear. Hearing Research 2020;394:107857. [DOI: 10.1016/j.heares.2019.107857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
2 Forouzandeh F, Borkholder DA. Microtechnologies for inner ear drug delivery. Curr Opin Otolaryngol Head Neck Surg 2020;28:323-8. [PMID: 32796268 DOI: 10.1097/MOO.0000000000000648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Verdoodt D, Peeleman N, Van Camp G, Van Rompaey V, Ponsaerts P. Transduction Efficiency and Immunogenicity of Viral Vectors for Cochlear Gene Therapy: A Systematic Review of Preclinical Animal Studies. Front Cell Neurosci 2021;15:728610. [PMID: 34526880 DOI: 10.3389/fncel.2021.728610] [Reference Citation Analysis]
4 Romito M, Pu Y, Stankovic KM, Psaltis D. Imaging hair cells through laser-ablated cochlear bone. Biomed Opt Express 2019;10:5974-88. [PMID: 31799058 DOI: 10.1364/BOE.10.005974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kurabi A, Cooper M, Spriggs M, Xu Y, Schaerer D, Ryan AF. Molecular Screening Strategy to Identify a Non-invasive Delivery Mechanism for the Treatment of Middle Ear Disorders. Front Med (Lausanne) 2020;7:503819. [PMID: 33392211 DOI: 10.3389/fmed.2020.503819] [Reference Citation Analysis]
6 Levie C, Moyaert J, Janssens de Varebeke S, Verdoodt D, Vanderveken OM, Topsakal V, Van Wijk E, de Vrieze E, Pennings R, Van de Berg R, Van Camp G, Ponsaerts P, Van Rompaey V. Attitudes of Potential Participants Towards Potential Gene Therapy Trials in Autosomal Dominant Progressive Sensorineural Hearing Loss. Otol Neurotol 2021;42:384-9. [PMID: 33555744 DOI: 10.1097/MAO.0000000000002981] [Reference Citation Analysis]
7 Lezirovitz K, Vieira-Silva GA, Batissoco AC, Levy D, Kitajima JP, Trouillet A, Ouyang E, Zebarjadi N, Sampaio-Silva J, Pedroso-Campos V, Nascimento LR, Sonoda CY, Borges VM, Vasconcelos LG, Beck RMO, Grasel SS, Jagger DJ, Grillet N, Bento RF, Mingroni-Netto RC, Oiticica J. A rare genomic duplication in 2p14 underlies autosomal dominant hearing loss DFNA58. Hum Mol Genet 2020;29:1520-36. [PMID: 32337552 DOI: 10.1093/hmg/ddaa075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Géléoc GGS, El-Amraoui A. Disease mechanisms and gene therapy for Usher syndrome. Hear Res 2020;394:107932. [PMID: 32199721 DOI: 10.1016/j.heares.2020.107932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
9 Maharajan N, Cho GW, Jang CH. Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration. In Vivo 2021;35:13-22. [PMID: 33402445 DOI: 10.21873/invivo.12227] [Reference Citation Analysis]
10 Zhang L, Wu X, Lin X. Gene therapy for genetic mutations affecting non-sensory cells in the cochlea. Hear Res 2020;394:107858. [PMID: 31791650 DOI: 10.1016/j.heares.2019.107858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ding N, Lee S, Lieber-Kotz M, Yang J, Gao X. Advances in genome editing for genetic hearing loss. Adv Drug Deliv Rev 2021;168:118-33. [PMID: 32387678 DOI: 10.1016/j.addr.2020.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Gheorghe DC, Niculescu AG, Bîrcă AC, Grumezescu AM. Nanoparticles for the Treatment of Inner Ear Infections. Nanomaterials (Basel) 2021;11:1311. [PMID: 34067544 DOI: 10.3390/nano11051311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bankoti K, Generotti C, Hwa T, Wang L, O'Malley BW Jr, Li D. Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss. Mol Ther Methods Clin Dev 2021;21:209-36. [PMID: 33850952 DOI: 10.1016/j.omtm.2021.03.005] [Reference Citation Analysis]
14 Lan Y, Tao Y, Wang Y, Ke J, Yang Q, Liu X, Su B, Wu Y, Lin CP, Zhong G. Recent development of AAV-based gene therapies for inner ear disorders. Gene Ther 2020;27:329-37. [PMID: 32424232 DOI: 10.1038/s41434-020-0155-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 de Joya EM, Colbert BM, Tang PC, Lam BL, Yang J, Blanton SH, Dykxhoorn DM, Liu X. Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy. Int J Mol Sci 2021;22:3910. [PMID: 33920085 DOI: 10.3390/ijms22083910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Crane R, Conley SM, Al-Ubaidi MR, Naash MI. Gene Therapy to the Retina and the Cochlea. Front Neurosci 2021;15:652215. [PMID: 33815052 DOI: 10.3389/fnins.2021.652215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ghosh S, Lewis MB, Walters BJ. Comparison of ethylenediaminetetraacetic acid and rapid decalcificier solution for studying human temporal bones by immunofluorescence. Laryngoscope Investig Otolaryngol 2020;5:919-27. [PMID: 33134540 DOI: 10.1002/lio2.449] [Reference Citation Analysis]
18 Ren Y, Chari DA, Vasilijic S, Welling DB, Stankovic KM. New developments in neurofibromatosis type 2 and vestibular schwannoma. Neurooncol Adv 2021;3:vdaa153. [PMID: 33604573 DOI: 10.1093/noajnl/vdaa153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Van Rompaey V. Making the Case for Research on Disease-Modifying Treatments to Tackle Post-lingual Progressive Sensorineural Hearing Loss. Front Neurol 2020;11:290. [PMID: 32373054 DOI: 10.3389/fneur.2020.00290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Abbaspour Rodbaneh E, Panahi M, Rahimi B, Mokabber H, Farajollahi R, Davarnia B. GJB2 mutations in Iranian Azeri population with autosomal recessive nonsyndromic hearing loss (ARNSHL): First report of c.238 C>A mutation in Iran. J Clin Lab Anal 2021;35:e24024. [PMID: 34581455 DOI: 10.1002/jcla.24024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Roccio M. Directed differentiation and direct reprogramming: Applying stem cell technologies to hearing research. Stem Cells 2021;39:375-88. [PMID: 33378797 DOI: 10.1002/stem.3315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]